MEBO治愈下肢慢性溃疡恶变患者一例报告

【】 目的 观察MEBO在下肢慢性溃疡恶变的治疗效果。方法 入院时予创面病理活检、微生物培养、摄片等检查。创面2次活检诊断：高分化鳞状上皮癌。给予抗感染、改善微循环等治疗,使用MEBO换药,每6小时一次,对纤维板给予划开清除,薄层削除老化、纤维化肉芽组织,使创面形成相对“新鲜”状态,重新培育肉芽。入院后22d,创面肉芽成熟后,再次多点活检病理检查,确认创面无明显癌组织后,行“邮票式”植皮手术,周围曲张静脉结扎及分段剥脱术。供皮区使用MEBO油纱换药,术后5日,植皮区改用MEBO油纱包扎换药,每日一次,直到愈合。结果 供皮区14d愈合,创面于术后30d痊愈,愈合后随访4年,无新的溃疡创面形成及无转移癌发生,创面有少量瘢痕形成。结论 MEBO能促进慢性溃疡创面的愈合,是人体肉芽生长的“培养基”,是慢性溃疡创面修复的一个良好外用药。它可能影响体表肿瘤的生物特性,抑制肿瘤细胞生长。     

MEBO在治疗骨烧伤创面中的应用体会

目的:总结在骨烧伤创面治疗中,使用MEBO烧伤膏促进肉芽组织生长后延期植皮的临床效果及创面愈合情况。方法:对骨烧伤创面使用MEBO及MEBO油纱包扎疗法。结果:38例患者骨烧伤创面未凿除坏死骨质,延期植皮后创面恢复良好。结论:运用此方法可减轻骨损伤、防止骨感染、提高移植皮片存活率、加速创面愈合。     

MEBO治疗皮肤癌的临床体会

目的 了解应用湿润烧伤膏（MEBO） 治疗皮肤癌的疗效.方法 随机选择56 例皮肤癌病例,均在局部浸润麻醉后单纯切除原发癌灶,不缝合创面,直接外涂MEBO 2 mm ~ 3 mm,无菌纱布包扎治疗,每日换药2次.分别在手术当时、术后7 d ~10 d、创面基本愈合时取基底部组织及手术切除的肿瘤组织进行病理活检.结果 56 例创面均愈合,创面基本愈合时基底部组织的病理活检均显示慢性肉芽肿伴感染.结论 单纯手术切除癌灶后,外用MEBO 治疗创面,创面出血少,患者无痛苦,并可避免扩大根治性手术对机体的再损伤,通过换药治疗后,创面无损伤愈合,并可无损伤地抑制残留肿瘤组织的生长,该类患者最终都是以炎性肉芽组织的形式愈合,这为皮肤癌的治疗提供了一种简单有效的新方法.     

MEBO油纱在深度烧伤创面换药中的应用

目的：探讨湿润烧伤膏（MEBO）油纱作为治疗深度烧伤创面内层敷料的治疗效果。方法：在深度创面换药中，以MEBO油纱作内层敷料，然后外用3～4层无菌纱布低张包扎治疗，每日换药1次或2次。结果：以MEBO油纱作为烧伤创面的内层敷料，更换敷料时可减轻创面疼痛、清除坏死组织较为彻底、创面不易感染，愈合快等优点。结论：MEBO油纱作为深度烧伤创面换药中的内层敷料使用，利于坏死组织脱落，不损伤创面肉芽组织，能促进创面愈合。     

MEBO治疗慢性难愈性皮肤溃疡的临床疗效观察

目的观察湿润烧伤膏(Moist Exposed Burn Ointment,MEBO)治疗慢性难愈性皮肤溃疡的临床疗效。方法对2010年1月-2014年12月收治的344例慢性难愈性皮肤溃疡患者创面采用"药刀结合"的方法治疗,药即MEBO,刀即外科清创术、植皮术等。患者初诊时尽量清除创面坏死组织,不能耐受一次性清创者行蚕食疗法;清创后创面均匀涂抹MEBO并外敷MEBO药纱包扎治疗,存在潜腔的创面用MEBO药纱填塞引流,待肉芽组织填满创面后行肉芽创面游离植皮术。观察患者创面愈合时间及愈合情况。结果344例患者中除38例患者好转后自动出院,3例患者死于基础疾病外,其余303例患者创面均完全愈合,愈合率达88.1%,创面平均愈合时间为80.4 d±15.8 d。其中,193例患者经MEBO换药治疗后创面自行愈合(56.1%);48例合并趾骨坏死的糖尿病足患者进行了坏死组织剜除术(14.0%);34例骨外露创面进行了钻孔术(9.9%);54例患者进行了肉芽创面植皮术(包括接受趾骨剜除术及骨钻孔术后的创面)。89例烧伤残余创面愈合较快,最短为7 d,最长为29 d,平均愈合时间为18.8 d±4.9 d。结论MEBO可有效控制创面感染,促进坏死组织液化脱落及肉芽组织生长,缩短创面愈合时间,减轻患者疼痛,适时配合"刀法"还可进一步加速坏死组织脱落,促进肉芽组织生长,及时封闭创面,减少瘢痕增生,是治疗慢性难愈性皮肤溃疡的理想方法。     

MEBT在烧伤植皮后创面应用的进一步探讨

本文介绍了35例50处烧伤肉芽创面行自体皮游离移植后，运用MEBT治疗并与传统包扎换药法作了比较。指出了手术前后及术中注意事项。对MEBO用药时机、植皮方法及皮片生长情况作了进一步探讨。指出肉芽创面植皮后，于术后2～3天首次打开敷料，即行MEBT治疗，可明显缩短创面愈合时间，避免了术后某些并发症的发生，利于肢体功能恢复，值得临床推广应用。     

MEBT/MEBO治疗足部Ⅲ度烧伤临床疗效分析

目的总结烧伤湿性医疗技术（MEBT／MEBO）在足部Ⅲ度烧伤治疗中的特点及愈合后的远、近期效果。方法对22例足部Ⅲ度烧伤患者全程采用MEBT／MEBO治疗,于烧伤后24h内对创面行皮肤耕耘减张术处理,并取创面组织做病理检查,明确烧伤深度。皮肤耕耘减张处理后,创面外用湿润烧伤膏（MEBO）换药治疗,每6h换药1次,液化期间,适当增加换药次数。对新愈合上皮组织进行活检,证实皮肤原位再生;伤后60d．对不能自愈的创面。在清除坏死组织、培养肉芽组织后行植皮手术治疗。结果22例患者全部治愈出院,其中植皮者4例,所有患者均未行二次整形手术,创面平均愈合时间为50．18d±16．39d,出院后随访1～10年,有8例出现轻度瘢痕增生,愈合效果满意。结论MEBT／MEBO有利于足部深度烧伤创面皮肤再生,减少致残率,最大限度地维持患肢的外观,值得临床推广应用。     

MEBO与微粒皮种植术治疗Ⅳ度压疮的临床体会

目的:回顾性总结应用MEBO结合自体微粒皮种植术治疗Ⅳ度压疮的临床效果,探讨其临床应用价值.方法:自2006年7月～2009年10月间,我科共收治16例31处Ⅳ度压疮患者,创面应用MEBO治疗,用无菌手术刀切除变性坏死的组织,待肉芽组织新鲜后施行微粒皮种植术,再用MEBO换药至创面修复.结果:11例24处Ⅳ度压疮溃疡面应用MEBO治疗后肉芽组织新鲜,施行微粒皮种植术后创面封闭;3例4处创面应用MEBO后溃疡面修复未植皮;1例2处施行微粒皮种植术后1周,创面新鲜皮片成活好,自动要求出院;1例住院25天坏死组织已去除,创面肉芽新鲜,创周上皮生长良好,因经济原因自动出院.结论:MEBO与自体微粒皮种植术结合治疗Ⅳ度压疮,溃疡面积明显缩小,修复后的皮肤柔软,修复的创面基本与正常皮肤面平行、瘢痕少,患者痛苦小,费用低.     

肉芽创面植皮后改用MEBT方法治疗的探讨

本文介绍了35例50处烧伤肉芽创面在自体皮游离移植术后，行MEBO治疗的经验，并与传统包扎换药法作了比较，并对MEBO的用药时机、植皮方法及皮片生长情况作了临床探讨。认为：肉芽创面植皮后，于术后2～3天首次打开敷料，即行MEBT治疗，可明显缩短创面愈合时间，能避免术后某些并发症的发生．有利于肢体功能的恢复，值得临床推广。肉芽创面植皮后改用MEBT方法治疗的探讨@张国强$滨洲医学院附院烧伤整形科!256603@刘桐林$滨洲医学院附院烧伤整形科!256603@韩学德$滨洲医学院附院烧伤整形科!256603…     

活性软组织覆盖物MEBO治疗ⅢB级开放性骨折创面病例报告

车祸中由于脱套伤、组织缺失导致的全层皮肤缺损非常常见,是骨科治疗的难点.临床治疗过程中使用湿润烧伤膏（MEBO） 作为活性软组织覆盖物培养骨折创面肉芽组织,然后再用皮肤原位再生复原技术（MEBT/ MEBO） 中的微粒皮种植术培养微粒皮,实现创面愈合.此疗法优点如下：1.有效避免骨暴露和长期换药引起的创面感染; 2.手术创伤小、风险低、操作简便; 3.仅使用少量皮源即可实现大面积创面封闭; 4.供皮区创面愈合后无功能障碍; 5.促进创面快速愈合; 6.创面愈合后皮肤外观及功能良好.     

Knee injury and Osteoarthritis Outcome Score (KOOS) - validation of a Swedish version

The Knee injury and Osteoarthritis Outcome Score (KOOS) is a self-administered instrument measuring outcome after knee injury at impairment, disability, and handicap level in five subscales. Reliability, validity, and responsiveness of a Swedish version was assessed in 142 patients who underwent arthroscopy because of injury to the menisci, anterior cruciate ligament, or cartilage of the knee. The clinimetric properties were found to be good and comparable to the American version of the KOOS. Comparison to the Short Form-36 and the Lysholm knee scoring scale revealed expected correlations and construct validity. Item by item, symptoms and functional limitations were compared between diagnostic groups. High responsiveness was found three months after arthroscopic partial meniscectomy for all subscales but Activities of Daily Living.     

The acutely limping child

Acute limping may be the result of multiple pathologies in children. The differential diagnosis varies based on the age of the child. Irrespective of age, the initial imaging work-up includes AP and frog leg radiographs of the pelvis and ultrasound; MRI may sometimes be helpful. In children less than 3 years, infections and trauma are most frequent. MRI is the imaging modality of choice when osteomyelitis is clinically suspected. Between the ages of 3 and 10 years, transient synovitis of the hip and Legg-Calvé-Perthes disease are main considerations but infection, inflammation and focal bony lesions are also considered. In children over 10 years, slipped capital femoral epiphysis also is considered.     

Do Balance Board Training Programs Reduce the Risk of Ankle Sprains in Athletes?

Introduction Ankle sprains are the most common musculo-skeletal injury that occurs in athletes,particularly in sports that require jumping and landing on one foot such as soccer,and basketball(1-4).These injuries often result in significant time loss from participation,long-term disability,and have a major impact on health care costs and resources(5-8).     

High Intensity Interval Training:New Insights

KEY POINTS ·High-intensity interval training(HIT)is characterized by repeated sessions of relatively brief，intermittent exercise.often performed with an“a11 out”effort or at an intensity close to that which elicits peak oxygen uptake(i.e.，≥90%of VO2 peak).     

Endovascular management of carotid-cavernous fistulas

Objective To investigate endovascular treatment of traumatic direct carotid-cavernous fistulas （CCF） and their complications such as pseudoaneurysms. Methods： Over a five-year period, 22 patients with traumatic direct CCFs were treated endovascularly in our institution. Thirteen patients were treated once with the result of CCF occluded, 8 twice and 1 three times. Treatment modalities included balloon occlusion of the CCF, sacrifice of the ipsilateral internal carotid artery with detachable balloon, coll embolization of the cavernous sinus and secondary pseudoaneurysms, and covered-stem management of the pseudoaneurysms. Results All the direct CCFs were successfully managed endovascularly. Four patients developed a pseudoaneurysm after the occlusion of the CCF with an incidence of pseudoaneurysm formation of 18.2% （4/22）. A total number of 8 patients experienced permanent occlusion of the ICA with a rate of ICA occlusion reaching 36.4% （8/22）. Followed up through telephone consultation from 6 months to 5 years, all did well with no recurrence of CCF symptoms and signs. Conclusion Traumatic direct CCFs can be successfully managed with endovascular means. The pseudoaneurysms secondary to the occlusion of the CCFs can be occluded with stent-assisted coiling and implantation of covered stents.     

Developmental validation of the PowerPlex(®) ESI 16 and PowerPlex(®) ESI 17 Systems: STR multiplexes for the new European standard

In response to the ENFSI and EDNAP groups’ call for new STR multiplexes for Europe, Promega^® developed a suite of four new DNA profiling kits. This paper describes the developmental validation study performed on the PowerPlex^® ESI 16 (European Standard Investigator 16) and the PowerPlex^® ESI 17 Systems. The PowerPlex^® ESI 16 System combines the 11 loci compatible with the UK National DNA Database^®, contained within the AmpFlSTR^® SGM Plus^® PCR Amplification Kit, with five additional loci: D2S441, D10S1248, D22S1045, D1S1656 and D12S391. The multiplex was designed to reduce the amplicon size of the loci found in the AmpFlSTR^® SGM Plus^® kit. This design facilitates increased robustness and amplification success for the loci used in the national DNA databases created in many countries, when analyzing degraded DNA samples. The PowerPlex^® ESI 17 System amplifies the same loci as the PowerPlex^® ESI 16 System, but with the addition of a primer pair for the SE33 locus. Tests were designed to address the developmental validation guidelines issued by the Scientific Working Group on DNA Analysis Methods (SWGDAM), and those of the DNA Advisory Board (DAB). Samples processed include DNA mixtures, PCR reactions spiked with inhibitors, a sensitivity series, and 306 United Kingdom donor samples to determine concordance with data generated with the AmpFlSTR^® SGM Plus^® kit. Allele frequencies from 242 white Caucasian samples collected in the United Kingdom are also presented. The PowerPlex^® ESI 16 and ESI 17 Systems are robust and sensitive tools, suitable for the analysis of forensic DNA samples. Full profiles were routinely observed with 62.5 pg of a fully heterozygous single source DNA template. This high level of sensitivity was found to impact on mixture analyses, where 54–86% of unique minor contributor alleles were routinely observed in a 1:19 mixture ratio. Improved sensitivity combined with the robustness afforded by smaller amplicons has substantially improved the quantity of data obtained from degraded samples, and the improved chemistry confers exceptional tolerance to high levels of laboratory prepared inhibitors.     

Bronchial stump fistula :treatment with covered retrievable hinged metallic stents-preliminary clinical experience

Objective To evaluate the preliminaily clinical efficacy and retrievability of a retrievable hinged covered metallic stent in the treatment of the bronchial stump fistula （BSF）. Methods Between April 2003 and March 2005, 8 patients with bronchial stump fistula after pneumonectomy or lobectomy were treated with two types （A and B） of retrievable hinged covered metallic stents. Type A stent was placed in 6 patients and type B in 2 under fluoroscopic guidance. The stent was removed with a retrieval set when BSF was healed or complications occurred. Results Stent placement in the bronchial tree was technically successful in all patients, without procedure-related complications. Immediate closure of the BSF was achieved in all patients after the procedure. Stents were removed from all patients but one. Removal of the stents was difficult in two patients due to tissue hyperplasia. Patients were followed up for 6 - 21 months. Placement of the stents remained stable in all patients except one due to severe cough. Permanent closure of BSF was achieved in 7 （87.5%） of 8 patients. Conclusion Use of a retrievable hinged covered expandable metallic stent is a simple, safe, and effective procedure for closure of the BSF. Retrieval of the stent seems to be feasible. （J Intervent Radiol, 2007, 16： 253-257）     

Prevalence and severity of hip and groin pain in sub‐elite male football: a cross‐sectional cohort study of 695 players

The purpose of this study was twofold: (a) to investigate the prevalence of hip and groin pain in sub‐elite male adult football in Denmark and (b) to explore the association between prevalence and duration of hip and groin pain in the previous season with the Copenhagen Hip and Groin Outcome Score (HAGOS) in the beginning of the new season. In total 695 respondents from 40 teams (Division 1–4) were included. Players completed in the beginning of the new season (July–Sept 2011) a self‐reported paper questionnaire on hip and/or groin pain during the previous season and HAGOS. In total 49% (95% CI: 45–52%) reported hip and/or groin pain during the previous season. Of these, 31% (95% CI: 26–36%) reported pain for >6 weeks. Players with the longest duration of pain during the previous season had the lowest HAGOS scores, when assessed at the beginning of the new season, P < 0.001. This study documents that half of sub‐elite male adult football players report pain in the hip and/or groin during a football season. The football players with the longest duration of pain in previous season displayed the lowest HAGOS scores in the beginning of the new season.